Astellas Pharma Inc. sued OSI Pharmaceuticals Inc. over its rejection of a $3.5 billion hostile takeover bid aimed at helping the Japanese company expand in cancer treatments.
More...
Toggle signature
||||| Mentor Group Access Now! |||||
More...
Toggle signature
||||| Mentor Group Access Now! |||||